AcelRx Pharmaceuticals Inc. (ACRX) is Trading Higher on Unusual Volume for January 26

Equities Staff |

AcelRx Pharmaceuticals Inc. (ACRX) experienced unusually high volume on Jan. 26, as the stock gained 21.72% to a closing price of $3.81. The stock saw 1.36 million shares trade hands over the course of the day on 3,920 trades. Given that the stock’s average daily volume over the last month has been 534,963 shares a day, this represents a pretty substantial spike over the norm.

AcelRx Pharmaceuticals Inc. has a P/B ratio of 4.23. The stock has traded between $9.32 and $2.59 over the last 52-weeks, its 50-day SMA is now $4.28, and its 200-day SMA $4.04.

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of therapies for the treatment of acute pain.

Headquartered in Redwood City, CA, AcelRx Pharmaceuticals Inc. has 32 employees and is currently under the leadership of CEO Howard Rosen.

For a complete fundamental analysis analysis of AcelRx Pharmaceuticals Inc., check out’s Stock Valuation Analysis report for ACRX. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

GSV Capital Corp

GSV Capital Corp is an externally managed, non-diversified closed-end management investment company. The Company has elected to be treated as a business development company.

Private Markets


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.


Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…